EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic potential and molecular mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San in the treatment of colorectal cancer

Jinxiao Li, Keke Jiang, Shuhan Wang, Yuju Cai, Luorui Shang, Fangyuan Zhou, Yuqing Wang, Jianghua Huang, Shan Hu, Qian Yan, Shenglan Yang

Frontiers in Pharmacology · 14.08.2026 · 17

DOI: 10.3389/fphar.2026.1813778 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 14.08.2026. Verfasst von Jinxiao Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Die Arbeit nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is one of the most common gastrointestinal tumors with elevated prevalence and high mortality rates, posing a serious threat to human health. As a commonly used classic prescription in the clinical treatment of CRC, Yi-Yi-Fu-Zi-Bai-Jiang-San (YYFZBJS), which is composed of Coix lacryma-jobi L., Aconitum carmichaelii Debeaux, and Patrinia scabiosifolia Fisch. ex Trev., exerts anti-CRC effects by regulating inflammation-cancer transformation, alleviating oxidative stress, restoring gut microbiota balance, inhibiting CRC cell proliferation, promoting apoptosis, regulating autophagy, suppressing tumor angiogenesis. It demonstrates multi-targeted anti-CRC potential and holds promising clinical value as a chemotherapy adjuvant. However, the molecular mechanisms underlying its multi-target anti-CRC effects remain incompletely elucidated and require comprehensive synthesis. This review summarizes the research progress of YYFZBJS in recent years in the field of CRC. It will provide theoretical basis and ideas for further investigation of the role of YYFZBJS in anti-CRC, with the ultimate goal of benefiting the clinical practice.

Schlagwörter

Stichwörter der Autor:innen

YYFZBJScolorectal cancergut microbiotamechanismresearch progress

Autor:innen und Institutionen

  • Department of Clinical Nutrition, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou, China.
  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, J., Jiang, K., Wang, S., Cai, Y., Shang, L., Zhou, F., Wang, Y., Huang, J., Hu, S., Yan, Q., & Yang, S. (2026). Therapeutic potential and molecular mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San in the treatment of colorectal cancer. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1813778

Vancouver

Li J, Jiang K, Wang S, Cai Y, Shang L, Zhou F, et al. Therapeutic potential and molecular mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San in the treatment of colorectal cancer. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1813778

BibTeX
@article{Li2026,
  author = {Li, Jinxiao and Jiang, Keke and Wang, Shuhan and Cai, Yuju and Shang, Luorui and Zhou, Fangyuan and Wang, Yuqing and Huang, Jianghua and Hu, Shan and Yan, Qian and Yang, Shenglan},
  title = {Therapeutic potential and molecular mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San in the treatment of colorectal cancer},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1813778}
}
Kostenlos starten →